Regenerative medicine is transitioning from the lab to the clinic and facing a shifting regulatory landscape, constrained clinical manufacturing capacity, and limited sites with stem cell clinical trial experience. Working with California Institute for Regenerative Medicine (CIRM) and its Alpha Stem Cell Clinics, the Stem Cell Center plays a role in providing guidance and infrastructure to address these challenges.